Marex Group plc Announces Launch of a Public Offering
Marex Group plc (Nasdaq: MRX) has announced the launch of a public offering of its ordinary shares. The offering involves 7,000,000 ordinary shares being sold by certain selling shareholders. Additionally, these shareholders have granted the underwriters a 30-day option to purchase up to 1,050,000 additional shares. Marex itself is not selling any shares and will not receive any proceeds from the sale.
The joint lead book-running managers for the offering are Barclays, Goldman Sachs & Co. , Jefferies, and Keefe, Bruyette & Woods. The offering will be made through a prospectus, which can be obtained from the underwriters. A registration statement has been filed with the SEC but is not yet effective, meaning the securities cannot be sold until it becomes effective.
Marex Group plc (Nasdaq: MRX) ha annunciato il lancio di un'offerta pubblica delle sue azioni ordinarie. L'offerta prevede la vendita di 7.000.000 azioni ordinarie da parte di alcuni azionisti venditori. Inoltre, questi azionisti hanno concesso agli underwriter un'opzione di 30 giorni per acquistare fino a 1.050.000 azioni aggiuntive. Marex stesso non sta vendendo alcuna azione e non riceverà alcun provento dalla vendita.
I gestori principali congiunti dell'offerta sono Barclays, Goldman Sachs & Co., Jefferies e Keefe, Bruyette & Woods. L'offerta sarà effettuata tramite un prospetto, che può essere ottenuto dagli underwriter. Una dichiarazione di registrazione è stata presentata alla SEC, ma non è ancora efficace, il che significa che i titoli non possono essere venduti fino a quando non diventa efficace.
Marex Group plc (Nasdaq: MRX) ha anunciado el lanzamiento de una oferta pública de sus acciones ordinarias. La oferta implica la venta de 7.000.000 de acciones ordinarias por parte de ciertos accionistas vendedores. Además, estos accionistas han otorgado a los suscriptores una opción de 30 días para comprar hasta 1.050.000 acciones adicionales. Marex no está vendiendo ninguna acción y no recibirá ingresos por la venta.
Los gerentes principales conjuntos de la oferta son Barclays, Goldman Sachs & Co., Jefferies y Keefe, Bruyette & Woods. La oferta se realizará a través de un prospecto, que se puede obtener de los suscriptores. Se ha presentado una declaración de registro a la SEC, pero aún no es efectiva, lo que significa que los valores no se pueden vender hasta que se vuelva efectiva.
Marex Group plc (Nasdaq: MRX)가 자사의 보통주에 대한 공모 시작을 발표했습니다. 이 공모는 특정 판매 주주가 판매하는 7,000,000 보통주를 포함합니다. 또한, 이 주주들은 인수인에게 1,050,000 추가 주식을 구매할 수 있는 30일 옵션을 부여했습니다. Marex는 주식을 판매하지 않으며, 판매로부터 어떤 수익도 받지 않습니다.
이번 공모의 공동 주관사들은 Barclays, Goldman Sachs & Co., Jefferies, 그리고 Keefe, Bruyette & Woods입니다. 이 공모는 인수인에게서 받을 수 있는 서류를 통해 이루어질 예정입니다. 등록 명세서가 SEC에 제출되었지만 아직 효력이 발생하지 않아 증권은 효력이 발생할 때까지 판매될 수 없습니다.
Marex Group plc (Nasdaq: MRX) a annoncé le lancement d'une offre publique de ses actions ordinaires. L'offre implique la vente de 7.000.000 d'actions ordinaires par certains actionnaires vendeurs. De plus, ces actionnaires ont accordé aux souscripteurs une option de 30 jours pour acheter jusqu'à 1.050.000 actions supplémentaires. Marex ne vend pas d'actions et ne recevra aucun produit de la vente.
Les co-managers principaux de l'offre sont Barclays, Goldman Sachs & Co., Jefferies et Keefe, Bruyette & Woods. L'offre sera effectuée par le biais d'un prospectus, qui peut être obtenu auprès des souscripteurs. Une déclaration d'enregistrement a été déposée auprès de la SEC mais n'est pas encore effective, ce qui signifie que les valeurs mobilières ne peuvent pas être vendues tant qu'elles ne deviennent pas effectives.
Marex Group plc (Nasdaq: MRX) hat den Start eines öffentlichen Angebots seiner Stammaktien bekannt gegeben. Das Angebot umfasst den Verkauf von 7.000.000 Stammaktien durch bestimmte verkaufende Aktionäre. Zusätzlich haben diese Aktionäre den Underwritern eine 30-tägige Option eingeräumt, bis zu 1.050.000 zusätzliche Aktien zu kaufen. Marex selbst verkauft keine Aktien und erhält keine Erlöse aus dem Verkauf.
Die gemeinsamen hauptverantwortlichen Manager für das Angebot sind Barclays, Goldman Sachs & Co., Jefferies und Keefe, Bruyette & Woods. Das Angebot wird durch einen Prospekt durchgeführt, der von den Underwritern bezogen werden kann. Eine Registrierungsanmeldung wurde bei der SEC eingereicht, ist jedoch noch nicht wirksam, was bedeutet, dass die Wertpapiere verkauft werden können, bis sie wirksam wird.
- Potential increase in market liquidity for MRX shares
- Opportunity for existing shareholders to monetize their investments
- Potential dilution of existing shareholders' ownership
- No proceeds from the offering will benefit the company directly
Insights
The launch of a public offering by Marex Group plc's selling shareholders is a significant event for investors. The offering of 7,000,000 ordinary shares, with an option for an additional 1,050,000 shares, suggests substantial insider selling. This could be interpreted as a lack of confidence from major shareholders or simply a desire to capitalize on the company's current valuation.
It's important to note that Marex itself is not selling any shares or receiving proceeds from this offering. This means the company's capital structure and cash position remain unchanged. However, the increased float may impact stock liquidity and potentially affect short-term price dynamics.
The involvement of major underwriters like Barclays and Goldman Sachs lends credibility to the offering. Investors should closely monitor the pricing and demand for these shares, as it will provide insights into market sentiment towards Marex. The success or struggle of this offering could influence future capital raising opportunities for the company.
This public offering by Marex Group's selling shareholders presents an interesting market dynamic. With a current market cap of
Investors should consider the following implications:
- Potential downward pressure on stock price due to increased supply
- Enhanced liquidity for the stock, which could attract more institutional investors
- Possible shift in shareholder composition, potentially affecting corporate governance
The timing of this offering is also noteworthy. Investors should research recent company performance and industry trends to understand why selling shareholders are choosing to exit now. This could provide valuable insights into the company's future prospects and current valuation.
NEW YORK, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Marex Group plc (Nasdaq: MRX) (“Marex”), the diversified global financial services platform, today announces the launch of a public offering of its ordinary shares (the “Offering”) by certain selling shareholders (the “Selling Shareholders”). The Selling Shareholders are offering a total of 7,000,000 ordinary shares. In connection with the Offering, the Selling Shareholders have granted the underwriters a 30-day option to purchase up to an additional 1,050,000 ordinary shares.
Marex is not selling any ordinary shares in the Offering and will not receive any proceeds from the sale of shares by the Selling Shareholders.
Barclays, Goldman Sachs & Co. LLC, Jefferies, and Keefe, Bruyette & Woods, a Stifel Company, are acting as joint lead book-running managers and as representatives of the underwriters for the proposed Offering.
The proposed Offering will be made only by means of a prospectus. Copies of the preliminary prospectus relating to the proposed Offering may be obtained from:
- Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at 1-888-603-5847, or by email at barclaysprospectus@broadridge.com;
- Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, New York 10282, via telephone: 1-866-471-2526, or via email: prospectus-ny@ny.email.gs.com;
- Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, New York, NY 10022, by phone at (877) 821-7388, or by email at Prospectus_Department@Jefferies.com; or
- Keefe, Bruyette & Woods Inc., 787 Seventh Avenue, Fourth Floor, New York, NY 10019, attention: Equity Capital Markets, or by calling toll free at (800) 966-1559 or emailing USCapitalMarkets@kbw.com.
A registration statement relating to these securities has been filed with the U.S. Securities and Exchange Commission but has not yet become effective. These securities may not be sold, nor may offers to buy these securities be accepted, prior to the time the registration statement becomes effective. This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities, and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of that jurisdiction.
FAQ
How many shares are being offered in Marex Group's (MRX) public offering?
Will Marex Group (MRX) receive any proceeds from this public offering?
Who are the underwriters for Marex Group's (MRX) public offering?
Has the registration statement for Marex Group's (MRX) offering become effective?
